Contact
Please use this form to send email to PR contact of this press release:
Nabriva Therapeutics Announces $38 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
TO:
Please use this form to send email to PR contact of this press release:
Nabriva Therapeutics Announces $38 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
TO: